Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.32 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26381544 | 0.77 | ALDH1A1 (0.34) | ALDH1A1TSHRMAPK1SMN1; SMN2RECQL | |
| SCHEMBL23075936 | 0.77 | ALDH1A1 (0.34) | ALDH1A1TSHRMAPK1SMN1; SMN2RECQL | |
| SCHEMBL18769619 | 0.73 | ALDH1A1 (0.37) | ALDH1A1TSHRMAPK1SMN1; SMN2RECQL | |
| SCHEMBL18768283 | 0.73 | SMN1; SMN2 (0.43) | ALDH1A1TSHRMAPK1SMN1; SMN2RECQL | |
| SCHEMBL578268 | 0.70 | ALDH1A1 (0.39) | ALDH1A1TSHRMAPK1SMN1; SMN2RECQL | |
| SCHEMBL1036790 | 0.70 | SMN1; SMN2 (0.39) | ALDH1A1TSHRMAPK1SMN1; SMN2RECQL | |
| SCHEMBL2448262 | 0.70 | ALDH1A1 (0.35) | ALDH1A1TSHRMAPK1SMN1; SMN2RECQL | |
| SCHEMBL2441210 | 0.69 | ALDH1A1 (0.38) | ALDH1A1TSHRMAPK1SMN1; SMN2RECQL | |
| SCHEMBL2441206 | 0.68 | SMN1; SMN2 (0.42) | ALDH1A1TSHRMAPK1SMN1; SMN2RECQL | |
| SCHEMBL19734813 | 0.67 | ALDH1A1 (0.40) | ALDH1A1TSHRMAPK1SMN1; SMN2MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021046447-A1 | HETEROCYCLIC RIP1 KINASE INHIBITORS | RIGEL PHARMACEUTICALS, INC. (US) | 2021-03-11 | — | — | WO | disclosed |